Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Jarratt Pytell to Methadone

This is a "connection" page, showing publications Jarratt Pytell has written about Methadone.

 
Connection Strength
 
 
 
0.799
 
  1. Pytell JD, Sharfstein JM, Olsen Y. Additional Barriers to Methadone Use in Hospitals and Skilled Nursing Facilities-Reply. JAMA Intern Med. 2020 04 01; 180(4):615.
    View in: PubMed
    Score: 0.548
  2. Pytell JD, Sharfstein JM, Olsen Y. Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities. JAMA Intern Med. 2020 01 01; 180(1):7-8.
    View in: PubMed
    Score: 0.135
  3. Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. J Subst Use Addict Treat. 2023 07; 150:209055.
    View in: PubMed
    Score: 0.042
  4. Levander XA, Pytell JD, Stoller KB, Korthuis PT, Chander G. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership. Subst Abus. 2022; 43(1):633-639.
    View in: PubMed
    Score: 0.038
  5. Callan J, Pytell J, Ross J, Rastegar DA. Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study. J Addict Med. 2020 Sep/Oct; 14(5):e274-e276.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)